https://www.businesswire.com/news/home/20260414178829/en/BioTesserae-Conducts-Milestone-First-in-Dog-Studies-with-Proprietary-PD-1-Single-Domain-Antibody
BioTesserae Conducts Milestone First in Dog Studies with Proprietary PD-1 Single Domain Antibody
BioTesserae Inc. (BTC), a biotechnology company focused on innovative veterinary therapeutics, in collaboration with Sunflower Therapeutics PBC, a public ben...